Taiwan
AnnJi Pharma and Avenue Therapeutics Enter Licensing Agreement for Clinical Asset AJ201 to Treat Kennedy's Disease.
Under the terms of the license agreement, AnnJi will receive upfront payments of $3 million and is entitled to receive future development, regula...
March 13, 2023 | News
BRIM appoints Andrew Lin as Chairman and Dr. Wen Chyi Shyu as CEO, secures $18M in Series E funding, and advances clinical trials for Dry Eye Disease and Neurotrophic Keratitis treatments
What led to the decision to elect Andrew Lin as the new Chairman of the Board, and how do you believe he will contribute to BRIM's continued succ...
March 01, 2023 | Opinion
BRIM Biotechnology announces new leadership team
BRIM Biotechnology, Inc. (BRIM, TPEx 6885), a clinical-stage company developing novel regenerative therapies to help combat and cure ophthalmology and...
February 21, 2023 | News
Gilead to present data at APASL 2023 on effective models for monitoring and treating hepatitis C and efficacy of antiviral treatments for HIV-1 and HBV-coinfected adults
-- Study recommends a simplified strategy for baseline testing and minimal monitoring for treatment of hepatitis C virus (HCV) infection with ...
February 15, 2023 | News
Ubitus and Smart Surgery enable doctors to practice robotic surgery with VR streaming
Immersive simulation surgery practice with VR gears Ample practices are required for a medical student or even a doctor to become a skillful surgeon opera...
December 23, 2022 | News
BRIM Biotechnology, Inc. raises $20 million in Series E funding round
Since the company’s inception in 2013, BRIM has successfully developed several platform technologies, including the regenerative peptide technology (...
December 05, 2022 | News
Medeologix Acquires Three Silicon Valley Medical Device CDMO Companies
Medeologix, a Taiwan MedTech CDMO company announces its successful acquisition of three premier medical device manufacturing companies to form an integrate...
November 29, 2022 | News
Everest Medicines Announces Major Regulatory Updates in Taiwan and South Korea
-- Taiwan Food and Drug Administration grants Accelerated Approval Designation (AAD) to Nefecon -- -- Ministry of Food and Drug Safety in S...
November 28, 2022 | News
Qmed Asia Eyes APAC Expansion with Digital Health Solutions
Qmed Asia’s whirlwind MOU signings with MeetDoctor in Cambodia and Eucare Co. Ltd. from Taiwan to enable access to reliable and affordable digital ...
November 18, 2022 | News
Axiomtek launches the newest medical grade artificial intelligence computing system - mBOX100
This slim-type medical system complies with the IEC-60601 medical safety standard for use in a variety of hospital applications and healthcare environments...
November 10, 2022 | News
AeroRx Partners with HCmed to Develop a Nebulized LABA/LAMA Combination Solution
AeroRx Therapeutics, LLC. (AeroRx) and HCmed Innovations Co., Ltd. (HCmed) have initiated a collaboration, introducing a LABA/LAMA combination solution for...
October 03, 2022 | News
First-Ever Spinal Surgical Hand-held Robot by Point Robotics MedTech to Make Its Worldwide Debut in the United States
Point Robotics MedTech Inc. (Point Robotics), a rising star in the field of orthopedic surgery, received 510(k) clearance from the U.S. Food and Drug Admin...
September 29, 2022 | News
AAHRPP Accredits Five More Research Organizations, Including First in Japan
At its September meeting, AAHRPP's Council on Accreditation awarded full accreditation to: Adventist Health Glendale, Glendale, California, a hospi...
September 26, 2022 | News
Juniper Biologics signs exclusive license agreement with Helsinn Healthcare SA for LEDAGA® (chlormethine) in Australia, Asia and the Middle East
Giorgio Calderari, Helsinn CEO commented: "I am pleased to announce this agreement with Juniper Biologics today which further widens the geographic di...
September 02, 2022 | News
Most Read
- Why Cell Therapy Systems Are Going Automatic: A New Era of Manufacturing
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Ravindra Rao Joins GOBI Technologies as Director of Life Sciences – APAC
- Amgen Announces $900 Million Expansion of Ohio Biomanufacturing Facility, Boosting Investment to Over $1.4 Billion
- Thermo Fisher Scientific Appoints Former CVS Health CEO Karen S. Lynch to Board of Directors
- Merck KGaA Reshapes Leadership for the Future with Key Executive Moves
- Aarian Health Appoints Thomas Keller as Business Director to Drive Innovation and Growth
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
News
